Oscar Health (NYSE:OSCR) Upgraded to “Hold” at Barclays

Oscar Health (NYSE:OSCR) was upgraded by equities research analysts at Barclays from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Monday,Zacks.com reports.

Other analysts have also issued reports about the stock. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. UBS Group increased their target price on shares of Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research report on Friday, November 7th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Stephens started coverage on Oscar Health in a report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. Finally, Wall Street Zen cut Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus target price of $16.29.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $16.50 on Monday. The company has a market capitalization of $4.37 billion, a PE ratio of -14.73 and a beta of 1.90. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. The stock has a fifty day moving average of $15.94 and a 200-day moving average of $17.02. Oscar Health has a one year low of $11.20 and a one year high of $23.80.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The business had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.Oscar Health’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter last year, the company posted ($0.22) EPS. As a group, equities analysts anticipate that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 286,182 shares of the business’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14. Following the completion of the sale, the insider owned 501,148 shares of the company’s stock, valued at $7,652,529.96. The trade was a 36.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Janet Liang sold 7,338 shares of the company’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $121,737.42. Following the sale, the insider owned 172,527 shares of the company’s stock, valued at approximately $2,862,222.93. This trade represents a 4.08% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 383,307 shares of company stock valued at $5,919,555 in the last three months. 25.11% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC boosted its position in shares of Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after acquiring an additional 1,282 shares during the period. LRI Investments LLC raised its stake in Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock valued at $26,000 after purchasing an additional 975 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio bought a new position in shares of Oscar Health during the 1st quarter worth about $30,000. Finally, Atlantic Union Bankshares Corp acquired a new position in shares of Oscar Health during the second quarter valued at about $33,000. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.